SCHEMBL7966489

SCHEMBL7966489

CCCN([C]=O)N(CCC)CCC

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3469248 0.86 CA1 (0.31) CA1
SCHEMBL93284 0.78
SCHEMBL8128135 0.76 CA1 (0.31) CA1
SCHEMBL2170365 0.75 DNM1 (0.38) CA1
SCHEMBL93268 0.74 CA1 (0.35) CA1
SCHEMBL5254695 0.70 CA1 (0.31) CA1
SCHEMBL3279296 0.67 CA1 (0.39) CA1
SCHEMBL2915 0.67
SCHEMBL5235256 0.65 DNM1 (0.36) CA1
SCHEMBL270410 0.65 CA1 (0.34) CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300331-B1 DRUGS AS ANTITUMOR AGENTS OR ANTICARCINOGENIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
EP-1020446-A1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed